This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Dr. Maria Amann, PhD
Senior Principal Scientist at Roche Innovation Center Zurich
Speaker

Profile

Maria Amann, PhD., currently works as Senior Principal Scientist and head of the cell surface targeting unit at the Roche Innovation Center Zurich. She has more than 17 years of experience in drug discovery and preclinical development in cancer immunotherapy in the Biotech and pharma industry. Her repertoire spans 1st and 2nd Gen. T Cell Bispecifics, targeted cytokines, tumor targeted immune agonists and GlycoMabs, moving these therapeutics from the initial stages of target assessment through LI/LO phase towards the clinic. In her work she has developed advanced in vitro and in vivo models., and is dedicated to translating scientific knowledge into impactful patient treatments.

Agenda Sessions

  • CD19 Targeted Costimulatory Agonism: learning from Forward and Reverse Translation Approaches

    5:45pm